Article
New Druggable Targets for Rheumatoid Arthritis Based on Insights From Synovial Biology
21 Feb 2022
Abstract excerpt
pathogenic autoantibodies pre-date clinical symptom development by several years. Incompletely understood range of mechanisms trigger joint-homing, leading to clinically evident articular disease. Advances in therapeutic approaches and understanding pathogenesis have improved prognosis and likely remission. However, partial/non-response to conventional and biologic therapies witnessed in a subset of patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
